Benjamin L Palleiko

CIK 1366244 · CHIEF EXECUTIVE OFFICER · last filed 2026-06-11

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

3

Total Filings

64

Lifetime Open-Market Net

-$5.69M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
KALV CHIEF EXECUTIVE OFFICER 0 $27.00 $0 -$5.71M 56 2026-06-11
ORE PHARMACEUTICAL HOLDINGS INC. (ORXE) Delisted SVP & Chief Financial Officer $0 2 2010-01-20
PENWEST PHARMACEUTICALS CO (PPCO) Delisted SVP, Corporate Dev. & CFO 2,500 $16.3K 6 2008-06-18

Recent Filings · Page 3 of 7

64 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-05-23 KALV Mixed +13,251 -$118.7K EDGAR
2025-05-20 KALV Mixed +5,556 -$45.1K EDGAR
2025-03-10 KALV Mixed +8,956 -$79.8K EDGAR
2025-02-25 KALV Grant (A) $0 EDGAR
2025-02-19 KALV Mixed +4,259 -$50.1K EDGAR
2024-12-09 KALV Mixed +7,998 -$74.4K EDGAR
2024-11-19 KALV Mixed +15,798 -$133.3K EDGAR
2024-09-10 KALV Mixed +8,273 -$89.6K EDGAR
2024-08-21 KALV Mixed +15,980 -$170.8K EDGAR
2024-06-10 KALV Mixed +8,160 -$86.1K EDGAR
Showing 2130 of 64
Page 3 of 7
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.